Yatsen Holding Sets Record with 20 Research Submissions at IFSCC Congress

GUANGZHOU, China, Oct. 15, 2026 /CourierPR/ -- Yatsen Holding Limited, a leading China-based beauty group, has made a significant splash at the 36th IFSCC (International Federation of Societies of Cosmetic Chemists) Congress in Perth, Australia, by presenting a record 20 research submissions. This marks a notable doubling of the company's 2025 total and represents its fifth consecutive year of participation in the world's premier cosmetics science conference.

The submissions, which were selected from over 1,200 entries following rigorous three-round expert review, span nine cutting-edge fields, including advanced scientific mechanisms, active ingredient innovation, efficacy evaluation, skin microbiome, color cosmetics innovation, skin neuroscience, preservative and microbiological science, computational toxicology, and formulation & delivery system innovation. This diverse array of research highlights Yatsen's commitment to scientific innovation and its position as a frontrunner in the Chinese cosmetics sector.

At the congress, Yatsen's R&D Director, Yi Deng, delivered a compelling podium presentation on a novel microbiology testing methodology. This method minimizes preservative interference and reduces false negatives, setting a new quality assurance standard that better reflects real-world cosmetic production conditions. The presentation underscored the company's dedication to translating cutting-edge science into high-efficacy beauty solutions for consumers worldwide.

Yatsen's major brands, including DR.WU, Galénic, Eve Lom, and Perfect Diary, also showcased technological applications across various areas such as gentle skincare, anti-aging, eye-area care, clinical skin research, and color cosmetics innovation. These contributions further cemented the company's reputation as a leader in the cosmetics industry.

Yatsen's sustained investment in research and development (R&D) is evident in its substantial financial commitment. The company has invested over RMB 770 million in R&D, with annual spending exceeding 3% of revenue for four consecutive years. As of June 30, 2026, Yatsen had filed 282 patent applications and published 55 academic papers, demonstrating its ongoing commitment to innovation and scientific advancement.

Founded in 2016, Yatsen Holding Limited aims to become a world-class beauty innovation pioneer. Its brands cover a wide range of consumer segments, from mass market to prestige and clinical-grade skincare. The company's robust R&D network includes an advanced manufacturing hub, three global R&D centers, six joint laboratories, and more than 20 joint research platforms. This comprehensive structure ensures that Yatsen can consistently deliver cutting-edge products and solutions to its global customer base.